Occurrence of mild cognitive impairment with hyperinsulinaemia in Africans with advanced type 2 diabetes mellitus
- PMID: 35746970
- PMCID: PMC9210459
- DOI: 10.1016/j.ibneur.2022.02.003
Occurrence of mild cognitive impairment with hyperinsulinaemia in Africans with advanced type 2 diabetes mellitus
Abstract
There is paucity of information on the prevalence of mild cognitive impairment (MCI) among individuals with type 2 diabetes mellitus (T2DM) in sub-Saharan Africa, including Nigeria. In addition, the role of hyperinsulinaemia in the development of MCI needs further investigation. This study sought to assess cognition and hyperinsulinaemia, with the associated characteristics in patients with advanced T2DM. Cognition was assessed using Montreal cognitive assessment test (MoCA), while fasting plasma insulin was measured using an ELISA kit. Sixty one diabetic subjects and 32 non-diabetic controls, matched for age, gender and level of education were studied. The diabetics had MCI while the controls had normal cognitive function. About 88.5% of the diabetic subjects had MCI, in contrast with only 50% of the non-diabetic controls. The most significantly affected cognitive domains among the diabetics were executive function, naming, attention, abstraction and delayed recall. Among the diabetics, MCI correlated with age, weight and body mass index (BMI); and in addition, age and weight found to be significant predictors of MCI. Plasma insulin concentration among the diabetics (16.24 ± 13.5 µIU/ml) was more than twice that of the controls (7.59 ± 2.9 µIU/ml). Hyperinsulinaemia among the diabetics correlated with weight, BMI, blood pressure and fasting blood sugar (FBS). Glycated haemoglobin and FBS levels were higher among diabetics compared with the controls. In conclusion, Africans with advanced T2DM show multi-domain MCI with high prevalence, coexisting with hyperinsulinaemia. Majority of the patients have diabetic complications and poor glycaemic control. Hyperinsulinaemia may play a complementary role in the pathophysiology of MCI in T2DM.
Keywords: African population; Cognitive function; Dementia; Hyperinsulinaemia; Insulin; Mild cognitive impairment (MCI); Type 2 diabetes mellitus (T2DM).
© 2022 The Authors.
Conflict of interest statement
Authors declare no conflict of interests.
Similar articles
-
Analysis of correlation between the mild cognitive impairment (MCI) and level of adiponectin in elderly patients with type 2 diabetes mellitus (T2DM).Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5471-5477. doi: 10.26355/eurrev_201712_13937. Eur Rev Med Pharmacol Sci. 2017. PMID: 29243792
-
Increased plasma Interleukin-1β level is associated with memory deficits in type 2 diabetic patients with mild cognitive impairment.Psychoneuroendocrinology. 2018 Oct;96:148-154. doi: 10.1016/j.psyneuen.2018.06.014. Epub 2018 Jun 22. Psychoneuroendocrinology. 2018. PMID: 29957442
-
Cognitive Impairment and its Association with Glycemic Control in Type 2 Diabetes Mellitus Patients.Indian J Endocrinol Metab. 2019 May-Jun;23(3):353-356. doi: 10.4103/ijem.IJEM_24_19. Indian J Endocrinol Metab. 2019. PMID: 31641638 Free PMC article.
-
[Diabetes and Dementia].Brain Nerve. 2015 Jun;67(6):725-32. doi: 10.11477/mf.1416200208. Brain Nerve. 2015. PMID: 26062587 Review. Japanese.
-
Pathophysiology of type 2 diabetes in sub-Saharan Africans.Diabetologia. 2022 Dec;65(12):1967-1980. doi: 10.1007/s00125-022-05795-2. Epub 2022 Sep 27. Diabetologia. 2022. PMID: 36166072 Free PMC article. Review.
Cited by
-
Overlooked cases of mild cognitive impairment: Implications to early Alzheimer's disease.Ageing Res Rev. 2024 Jul;98:102335. doi: 10.1016/j.arr.2024.102335. Epub 2024 May 12. Ageing Res Rev. 2024. PMID: 38744405 Free PMC article.
-
Cognitive impairment and associated factors among patients with diabetes mellitus in Africa: a systematic review and meta-analysis.Front Endocrinol (Lausanne). 2024 Jul 17;15:1386600. doi: 10.3389/fendo.2024.1386600. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39086905 Free PMC article.
-
Study of cognitive functions and their association with depression in type II diabetes mellitus.J Family Med Prim Care. 2024 Jun;13(6):2323-2328. doi: 10.4103/jfmpc.jfmpc_1150_23. Epub 2024 Jun 14. J Family Med Prim Care. 2024. PMID: 39027822 Free PMC article.
-
Prevalence and Associated Factors of Cognitive Dysfunction Among Middle-Aged Type 2 Diabetes Mellitus Patients in South India: A Cross-Sectional Study.Cureus. 2025 Jul 25;17(7):e88747. doi: 10.7759/cureus.88747. eCollection 2025 Jul. Cureus. 2025. PMID: 40861537 Free PMC article.
References
-
- Agrawal R., Tyagi E., Shukla R., Nath C. A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia. Neuropharmacology. 2009;56(4):779–787. - PubMed
-
- Biessels G.J., Janssen Jolien, van den Berg Esther, Zinman Bernard, Espeland Mark A., Mattheus Michaela, Johansen Odd Erik. Rationale and design of the CAROLINA® cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus. BMC Neurol. 2018;18:7. doi: 10.1186/s12883-018-1014-7. - DOI - PMC - PubMed
-
- Chen G.Q., Zhang6 Xin, Xing7,8 Yue, Wen9,10 Dong, Cui6 Guang-Bin, Han Ying. Resting-state functional magnetic resonance imaging shows altered brain network topology in Type 2 diabetic patients without cognitive impairment. Oncotarget. 2017:1–12. 〈www.impactjournals.com/oncotarget/〉 - PMC - PubMed
LinkOut - more resources
Full Text Sources